-+ 0.00%
-+ 0.00%
-+ 0.00%

Barclays Maintains Underweight on Definitive Healthcare, Lowers Price Target to $2.75

Benzinga·12/09/2025 16:33:33
Listen to the news
Barclays analyst Saket Kalia maintains Definitive Healthcare (NASDAQ:DH) with a Underweight and lowers the price target from $3 to $2.75.